Keyword Suggestion
Domain Informations
Blenrep.com lookup results from whois.safenames.net server:
- Domain created: 2014-06-20T09:57:12Z
- Domain updated: 2025-06-20T23:49:10Z
- Domain expires: 2026-06-20T09:57:12Z 0 Years, 158 Days left
- Website age: 11 Years, 206 Days
- Registrar Domain ID: 1863605972_DOMAIN_COM-VRSN
- Registrar Url: http://www.safenames.net
- Registrar WHOIS Server: whois.safenames.net
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +44.1908200022
- Name server:
- C1-160.AKASHIELD.NET
- C2-160.AKASHIELD.NET
Network
- inetnum : 23.32.0.0 - 23.67.255.255
- name : AKAMAI
- handle : NET-23-32-0-0-1
- status : Direct Allocation
- created : 1999-01-21
- changed : 2023-10-24
Owner
- organization : Akamai Technologies, Inc.
- handle : AKAMAI
- address : Array,Cambridge,MA,02142,US
Abuse
- handle : NUS-ARIN
- name : NOC United States
- phone : +1-617-444-2535
- email : [email protected]
Technical support
- handle : SJS98-ARIN
- name : Schecter, Steven Jay
- phone : +1-617-274-7134
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 23.49.248.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 23.49.248.20)
Spam Check (IP: 23.49.248.20)
Recent Searched Sites
› Genr8developments.com (4 seconds ago) / US
› Eddis.edu.ar (0 seconds ago) / AR
› Casino-in-deutschland.shop (1 seconds ago) / US
› Aaes.uada.edu (6 seconds ago) / US
› Edengrove.millerhare.com (1 seconds ago) / US
› Support.ssit.scl.cornell.edu (0 seconds ago) / US
› Eosinno.tech (1 seconds ago) / US
› The-crypto-contracts.com (2 seconds ago) / US
› Zzspider.com (0 seconds ago) / CN
› Ravenscroftgroup.com (2 seconds ago) / IE
› 11bet.win (2 seconds ago) / US
› Docfinderpro.com (0 seconds ago) / US
› Blenrep.com (0 seconds ago) / US
› Circle-irrgarten.bbs.fc2.com (0 seconds ago) / US
› Dornier.es (1 seconds ago) / ES
› Spg.olympicfoundry.com (3 seconds ago) / US
› Skynet.ru (4 seconds ago) / RU
› Mojo-hk.com (2 seconds ago) / US
› Sumareleiloes.com.br (0 seconds ago) / BR
› Psxextreme.pl (1 seconds ago) / PL
Websites Listing
We found Websites Listing below when search with blenrep.com on Search Engine
BLENREP Eye Drop Supportive Care Program
Phone Number*: Email Address: Middle Initial: Last Name*: ... BLENREP Eye Drop Supportive Care Program, 200 Pinecrest Plaza, Morgantown, WV 26505 US, but such a revocation would end my eligibility to participate in the eye drop program. (The revocation process may also be initiated by calling the Coordinating Center at 1-855-209-9188). Revoking this authorization will …
Blenrephcp.comBlenRep Together with GSK Oncology Enrollment Form
Address, e-mail address, and other information, you are giving GSK and companies working for or with GSK permission to contact you for marketing, market research, or advertising purposes, or to invite you to interact with GSK in other ways across multiple channels, eg, mail, email, websites, online advertising, applications, and services, regarding the medical condition(s) in which you …
Togetherwithgskoncology.comblenrep - Belantamab Mafodotin: Scheda Tecnica del Farmaco ...
2021-07-19 · BLENREP deve essere ricostituito e diluito da un operatore sanitario prima della somministrazione tramite infusione endovenosa. BLENREP deve essere infuso nell’arco di almeno 30 minuti (vedere paragrafo 6.6). 04.3 Controindicazioni. Indice. Ipersensibilità al principio attivo o ad uno qualsiasi degli eccipienti elencati al paragrafo 6.1.
Torrinomedica.itUnderstanding Blenrep - Wasabi
Blenrep (belantamab mafodotin-blmf) for injection. Founded in 1990, the International Myeloma Foundation (IMF) is the rst and largest organization focusing speci cally on multiple myeloma. The IMF s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention …
Imf-d8-prod.s3.us-west-1.wasabisys.comBlenrep® (belantamab mafodotin-blmf) - Moda Health
2021-03-01 · Blenrep® (belantamab mafodotin-blmf) (Intravenous) Document Number: IC-0561 Last Review Date: 03/01/2021 Date of Origin: 09/01/2020 Dates Reviewed: 09/2020, 01/2021, 03/2021 I. Length of Authorization Coverage will be provided for six months and may be renewed. II. Dosing Limits A. Quantity Limit (max daily dose) [NDC Unit]: Blenrep 100 mg powder for …
Modahealth.comSeagen - Seattle Genetics Achieves Milestone Payment Under ...
2020-08-06 · BLENREP was developed and will be commercialized by GSK. The approval triggers a $20 million milestone payment and entitles Seattle Genetics to royalties on BLENREP product sales. BLENREP was approved for the treatment of patients with relapsed or refractory multiple myeloma who have received at least four prior therapies including an anti-CD38 …
Investor.seagen.comUnderstanding Blenrep by International Myeloma ... - Issuu
2021-01-21 · Understanding. Blenrep. (belantamab mafodotin-blmf) for injection. A publication of the International Myeloma Foundation. Founded in 1990, the International Myeloma Foundation (IMF) is the first ...
Issuu.comEye Drop Supportive Care Program | GSK Oncology On Demand
BLENREP caused changes in the corneal epithelium resulting in changes in vision, including severe vision loss and corneal ulcer, and symptoms such as blurred vision and dry eyes. Conduct ophthalmic exams at baseline, prior to each dose, and promptly for worsening symptoms. Withhold BLENREP until improvement and resume, or permanently discontinue, based on …
Gskoncologyondemand.comFDA Approves GSK’s BLENREP for the Treatment of Patients ...
2020-08-06 · BLENREP employs a multi-faceted mechanism of action and is directed toward BCMA, a cell-surface protein that plays an important role in the survival of plasma cells and is expressed on multiple myeloma cells. ii The approval of BLENREP was based on six-month primary results from the pivotal DREAMM-2 study, which enrolled patients with relapsed or …
Pharmasalmanac.comGSK hiring Director, BLENREP REMS in Philadelphia ...
Posted 1:00:58 AM. Site Name: Field Worker - CHNPosted Date: Mar 16 2022Are you interested in an opportunity to…See this and similar jobs on LinkedIn.
Linkedin.comGSK gets EC nod for BLENREP to treat refractory multiple ...
DREAMM-2, an open-label study, randomised the patients in two arms to receive either 2.5 mg/kg or 3.4 mg/kg BLENREP Q3W. GSK R&D president and chief scientific officer Dr Hal Barron said: “The approval of BLENREP marks an important step forward for patients in Europe where nearly 50,000 new cases of multiple myeloma are diagnosed each year.
Pharmaceutical-business-review.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| clubdesireri.com | godaddy.com | -2 Years, -345 Days |
| antepyolu.com | isimtescil.net | -3 Years, -268 Days |
| gearside.com | cloudflare.com | -2 Years, -354 Days |
| jmbalmaceda.com | domains.google.com | -3 Years, -162 Days |
| woveninc.org | whois.godaddy.com | 1 Year, 125 Days |
| mrbcc.org | whois.godaddy.com | -3 Years, -282 Days |
| izmee.com | register.it | -3 Years, -164 Days |
| benningtongolf.com | gandi.net | -3 Years, -209 Days |
| eaglepointsol.com | godaddy.com | -2 Years, -139 Days |
| powkiddy.com | net.cn | -1 Years, -323 Days |